Submitted:
05 October 2024
Posted:
07 October 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Patient Population
2.2. Analysis of Anatomical Parameters
2.3. Calculation of AFMS
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Waller, D.K.; Correa, A.; Vo, T.M.; Wang, Y.; Hobbs, C.; Langlois, P.H.; Pearson, K.; Romitti, P.A.; Shaw, G.M.; Hecht, J.T. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A 2008, 146a, 2385–2389. [Google Scholar] [CrossRef] [PubMed]
- Moffitt, K.B.; Abiri, O.O.; Scheuerle, A.E.; Langlois, P.H. Descriptive epidemiology of selected heritable birth defects in Texas. Birth Defects Res A Clin Mol Teratol 2011, 91, 990–994. [Google Scholar] [CrossRef] [PubMed]
- Barbosa-Buck, C.O.; Orioli, I.M.; da Graça Dutra, M.; Lopez-Camelo, J.; Castilla, E.E.; Cavalcanti, D.P. Clinical epidemiology of skeletal dysplasias in South America. Am J Med Genet A 2012, 158a, 1038–1045. [Google Scholar] [CrossRef] [PubMed]
- Stevenson, D.A.; Carey, J.C.; Byrne, J.L.; Srisukhumbowornchai, S.; Feldkamp, M.L. Analysis of skeletal dysplasias in the Utah population. Am J Med Genet A 2012, 158a, 1046–1054. [Google Scholar] [CrossRef] [PubMed]
- Savarirayan, R.; Ireland, P.; Irving, M.; Thompson, D.; Alves, I.; Baratela, W.A.R.; Betts, J.; Bober, M.B.; Boero, S.; Briddell, J.; et al. International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia. Nat Rev Endocrinol 2022, 18, 173–189. [Google Scholar] [CrossRef] [PubMed]
- Bellus, G.A.; Hefferon, T.W.; Ortiz de Luna, R.I.; Hecht, J.T.; Horton, W.A.; Machado, M.; Kaitila, I.; McIntosh, I.; Francomano, C.A. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet 1995, 56, 368–373. [Google Scholar] [PubMed]
- Rousseau, F.; Bonaventure, J.; Legeai-Mallet, L.; Pelet, A.; Rozet, J.M.; Maroteaux, P.; Le Merrer, M.; Munnich, A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994, 371, 252–254. [Google Scholar] [CrossRef] [PubMed]
- Di Rocco, F.; Biosse Duplan, M.; Heuzé, Y.; Kaci, N.; Komla-Ebri, D.; Munnich, A.; Mugniery, E.; Benoist-Lasselin, C.; Legeai-Mallet, L. FGFR3 mutation causes abnormal membranous ossification in achondroplasia. Hum Mol Genet 2014, 23, 2914–2925. [Google Scholar] [CrossRef] [PubMed]
- Irving, M.; AlSayed, M.; Arundel, P.; Baujat, G.; Ben-Omran, T.; Boero, S.; Cormier-Daire, V.; Fredwall, S.; Guillen-Navarro, E.; Hoyer-Kuhn, H.; et al. European Achondroplasia Forum guiding principles for the detection and management of foramen magnum stenosis. Orphanet J Rare Dis 2023, 18, 219. [Google Scholar] [CrossRef] [PubMed]
- Ficke, J.; Varacallo, M. Anatomy, head and neck: Foramen Magnum. In StatPearls; StatPearls Publishing LLC.: Treasure Island (FL), 2024. [Google Scholar]
- Pauli, R.M.; Scott, C.I.; Wassman, E.R., Jr.; Gilbert, E.F.; Leavitt, L.A.; Ver Hoeve, J.; Hall, J.G.; Partington, M.W.; Jones, K.L.; Sommer, A.; et al. Apnea and sudden unexpected death in infants with achondroplasia. J Pediatr 1984, 104, 342–348. [Google Scholar] [CrossRef] [PubMed]
- Pauli, R.M. Achondroplasia: a comprehensive clinical review. Orphanet J Rare Dis 2019, 14, 1. [Google Scholar] [CrossRef] [PubMed]
- Pauli, R.M.; Horton, V.K.; Glinski, L.P.; Reiser, C.A. Prospective assessment of risks for cervicomedullary-junction compression in infants with achondroplasia. Am J Hum Genet 1995, 56, 732–744. [Google Scholar] [PubMed]
- Ruiz-Garcia, M.; Tovar-Baudin, A.; Del Castillo-Ruiz, V.; Rodriguez, H.P.; Collado, M.A.; Mora, T.M.; Rueda-Franco, F.; Gonzalez-Astiazaran, A. Early detection of neurological manifestations in achondroplasia. Childs Nerv Syst 1997, 13, 208–213. [Google Scholar] [CrossRef] [PubMed]
- Cheung, M.S.; Irving, M.; Cocca, A.; Santos, R.; Shaunak, M.; Dougherty, H.; Siddiqui, A.; Gringras, P.; Thompson, D. Achondroplasia Foramen Magnum Score: screening infants for stenosis. Arch Dis Child 2021, 106, 180–184. [Google Scholar] [CrossRef] [PubMed]
- Kunkel, P.; Al Halak, M.; Bechthold-Dalla Pozza, S.; Grasemann, C.; Keller, A.; Muschol, N.; Nader, S.; Palm, K.; Poetzsch, S.; Rohrer, T.; et al. Multidisciplinary approach in achondroplasia – real world experience after drug approval of vosoritide. In Proceedings of the Poster presented at the European Society for Paediatric Endocrinology (ESPE) annual conference, The Hague, Netherlands, 2023, 21-23 September; pp. 1–414.
- Dornheim Medical Images GmbH. Dornheim Segmenter. Available online: https://dornheim.tech/en/segmenter (accessed on 24 September 2024).
- Bianchi, F.; Benato, A.; Frassanito, P.; Tamburrini, G.; Massimi, L. Functional and morphological changes in hypoplasic posterior fossa. Childs Nerv Syst 2021, 37, 3093–3104. [Google Scholar] [CrossRef] [PubMed]
- Calandrelli, R.; Panfili, M.; D'Apolito, G.; Zampino, G.; Pedicelli, A.; Pilato, F.; Colosimo, C. Quantitative approach to the posterior cranial fossa and craniocervical junction in asymptomatic children with achondroplasia. Neuroradiology 2017, 59, 1031–1041. [Google Scholar] [CrossRef] [PubMed]
- Pascoe, H.M.; Yang, J.Y.; Chen, J.; Fink, A.M.; Kumbla, S. Macrocerebellum in achondroplasia: a further CNS manifestation of FGFR3 mutations? AJNR Am J Neuroradiol 2020, 41, 338–342. [Google Scholar] [CrossRef] [PubMed]



| Characteristic | Achondroplasia (N = 37) | Reference (N = 37) |
|---|---|---|
| Sex, n (%) | ||
| Male | 20 (54.1) | 23 (62.2) |
| Female | 17 (45.9) | 14 (37.8) |
| Age, yearsa | ||
| Mean (SD) | 1.1 (0.9) | 1.7 (1.3) |
| Median (range) | 0.8 (0.1–3.6) | 1.5 (0–3.9) |
| Decompression surgery, n (%) | ||
| Yes | 13 (35.1) | 0 |
| No | 23 (62.2) | 37 (100) |
| Parameter | Received surgery | Did not receive surgery | P-value* | |
|---|---|---|---|---|
| Foramen magnum diameter, mm | No. patients | 12 | 21 | < 0.1 |
| Mean (SD) | 8.6 (1.9) | 10.7 (2.2) | ||
| Median (range) | 8.5 (5.5–12.5) | 10.5 (7.5–16.6) | ||
| Foramen magnum area, mm2 | No. patients | 12 | 21 | 0.922 |
| Mean (SD) | 108.3 (31.5) | 109.4 (32.2) | ||
| Median (range) | 118.8 (49.6–155.4) | 111.8 (54.9–163.8) | ||
| Myelon area, mm2 | No. patients | 12 | 21 | 0.228 |
| Mean (SD) | 36.0 (14.2) | 43.3 (16.8) | ||
| Median (range) | 33.9 (16.5–66.9) | 39.3 (25.2–102.3) | ||
| Clivus length, mm | No. patients | 14 | 22 | 0.602 |
| Mean (SD) | 23.2 (3.2) | 23.7 (3.1) | ||
| Median (range) | 22.6 (19.5–32.5) | 23.3 (16.0–30.0) | ||
| Tentorium angle, degrees | No. patients | 14 | 21 | < 0.001 |
| Mean (SD) | 49.0 (4.4) | 46.6 (6.0) | ||
| Median (range) | 49.0 (43.5–57.0) | 47.0 (31.5–58.0) | ||
| Occipital angle, degrees | No. patients | 14 | 21 | 0.513 |
| Mean (SD) | 79.1 (5.8) | 77.0 (7.1) | ||
| Median (range) | 79.5 (70.0–89.5) | 78.5 (64.0–88.0) | ||
| Posterior fossa volume, mm3 | No. patients | 7 | 17 | 0.120 |
| Mean (SD) | 110,595.6 (20,307.3) | 132,456.8 (32,772.2) | ||
| Median (range) | 106,081.3 (84,624.6–140,277.7) | 134,941.4 (48,439.7–177,870.0) | ||
| Proportion of brainstem volume outside the posterior fossa, mm3 | No. patients | 7 | 17 | < 0.001 |
| Mean (SD) | 4698.3 (1034.4) | 4478.3 (1136.4) | ||
| Median (range) | 4532.0 (3233.8–6301.0) | 4428.4 (2778.6–7021.3) | ||
| Cerebellum volume, mm3 | No. patients | 7 | 17 | 0.782 |
| Mean (SD) | 90,139.4 (16,998.3) | 68,607.0 (51,701.3) | ||
| Median (range) | 86,698.1 (68,759.5–113,405.8) | 84,353.8 (98.7–141,281.0) | ||
| Supratentorial ventricular system volume, mm3 | No. patients | 12 | 20 | < 0.001 |
| Mean (SD) | 43,054.2 (28,955.2) | 41,467.1 (21,845.7) | ||
| Median (range) | 33,671.7 (16,830.3–115,394.5) | 35,651.9 (10,782.3–108,493.8) | ||
| Intracranial CSF system volume, mm3 | No. patients | 12 | 19 | < 0.001 |
| Mean (SD) | 221,020.3 (86,479.5) | 228,826.5 (71,079.6) | ||
| Median (range) | 189,483.0 (124,900.2–376,599.0) | 236,400.2 (118,999.2–337,691.4) | ||
| Fourth ventricle volume, mm3 | No. patients | 14 | 21 | 0.797 |
| Mean (SD) | 716.1 (318.5) | 772.5 (383.8) | ||
| Median (range) | 732.0 (292.0–1279.2) | 660.3 (319.6–1607.8) | ||
| Parameter | AFMS 1 or 2 | AFMS 3 or 4 | |
|---|---|---|---|
| Foramen magnum diameter, mm | No. patients | 14 | 7 |
| Mean (SD) | 10.2 (1.6) | 8.5 (1.5) | |
| Median (range) | 10.0 (7.5–13.0) | 8.5 (7.0–11.1) | |
| Foramen magnum area, mm2 | No. patients | 14 | 7 |
| Mean (SD) | 119.4 (35.3) | 97.2 (32.5) | |
| Median (range) | 120.8 (64.4–163.8) | 113.4 (49.6–129.9) | |
| Myelon area, mm2 | No. patients | 14 | 7 |
| Mean (SD) | 43.9 (19.4) | 32.5 (12.0) | |
| Median (range) | 38.4 (26.7–102.3) | 31.4 (16.5–47.0) | |
| Clivus length, mm | No. patients | 16 | 7 |
| Mean (SD) | 24.4 (3.2) | 22.3 (2.2) | |
| Median (range) | 24.3 (20.0–32.5) | 22.0 (19.5–25.5) | |
| Tentorium angle, degrees | No. patients | 16 | 7 |
| Mean (SD) | 47.7 (3.9) | 46.9 (3.9) | |
| Median (range) | 47.3 (38.0–56.5) | 45.0 (43.5–54.0) | |
| Occipital angle, degrees | No. patients | 16 | 7 |
| Mean (SD) | 78.7 (4.8) | 76.4 (5.8) | |
| Median (range) | 79.8 (70.5–85.0) | 75.0 (70.0–85.0) | |
| Posterior fossa volume, mm3 | No. patients | 10 | 3 |
| Mean (SD) | 121,354.9 (33,762.1) | 119,011.8 (34,362.1) | |
| Median (range) | 127,663.5 (48,439.7–174,505.8) | 106,081.3 (92,990.8–157,963.2) | |
| Proportion of brainstem volume outside the posterior fossa, mm3 | No. patients | 10 | 3 |
| Mean (SD) | 4227.0 (693.0) | 4823.3 (1633.2) | |
| Median (range) | 4448.4 (2778.6–5169.0) | 4739.1 (3233.8–6497.0) | |
| Cerebellum volume, mm3 | No. patients | 10 | 3 |
| Mean (SD) | 95,285.9 (30,564.1) | 93,927.2 (28,891.0) | |
| Median (range) | 100,206.7 (29,592.2–141,281.0) | 81,541.8 (73,293.8–126,946.0) | |
| Supratentorial ventricular system volume, mm3 | No. patients | 14 | 7 |
| Mean (SD) | 39,401.9 (24,497.0) | 41,211.5 (15,093.3) | |
| Median (range) | 33,539.9 (10,782.3–115,394.5) | 37,651.3 (25,549.6–62,386.6) | |
| Intracranial CSF system volume, mm3 | No. patients | 13 | 7 |
| Mean (SD) | 229,855.0 (88,536.2) | 201,651.5 (71,421.0) | |
| Median (range) | 198,043.8 (118,999.2–376,599.0) | 189,151.4 (124,900.2–337,691.4) | |
| Fourth ventricle volume, mm3 | No. patients | 16 | 7 |
| Mean (SD) | 831.5 (422.4) | 651.5 (254.4) | |
| Median (range) | 729.6 (338.3–1607.8) | 635.7 (356.5–982.6) | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).